Globus Medical upgraded by Needham with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for GMED
Across the 4 sessions after earlier GMED headlines, the stock closed higher 2 times and lower 2 times, with a median move of 2.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GMED | SPY |
|---|---|---|---|
| Jan 27, 2026 | TD Cowen initiated coverage on Globus Medical with a new price target | -1.1% | +0.4% |
| Jan 8, 2026 | Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results | +4.5% | -0.0% |
| Nov 7, 2025 | Globus Medical upgraded by Truist with a new price targetand 2 other headlines that session | +35.9% | +0.1% |
| Oct 28, 2025 | Stifel resumed coverage on Globus Medical with a new price target | -0.8% | +0.3% |
Keep researching GMED
- What is Analyst upgrade?A sell-side analyst's move to a more favorable rating on a stock, such as from Hold to Buy, usually published with a new price target and thesis.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- GMED insider tradesEvery buy and sale reported by Globus Medical Inc. officers, directors and large holders.
- GMED earnings historyPast Globus Medical Inc. earnings releases, newest first.
- GMED financial statementsRevenue, profit, cash flow and balance sheet from Globus Medical Inc.'s SEC filings.
Quantisnow market dataNYSE
GMED
Globus Medical Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2012
Get push alerts for GMED
Full GMED profile on Quantisnow Follow GMED and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time